Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $529,000.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Craig Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the completion of the sale, the director owned 1,150 shares in the company, valued at $529,000. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

ISRG stock opened at $452.80 on Friday. The firm has a market cap of $156.96 billion, a PE ratio of 54.75, a P/E/G ratio of 3.12 and a beta of 1.45. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The firm has a 50 day simple moving average of $409.93 and a 200 day simple moving average of $431.89.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.40 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in ISRG. Bank of New York Mellon Corp acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $1,335,753,000. Arrowstreet Capital Limited Partnership increased its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the last quarter. Assenagon Asset Management S.A. increased its position in Intuitive Surgical by 55.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock worth $633,505,000 after buying an additional 558,099 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Intuitive Surgical during the third quarter worth $136,743,000. Finally, Amundi raised its holdings in Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. TD Cowen reaffirmed a “buy” rating and set a $485.00 target price on shares of Intuitive Surgical in a report on Monday, October 19th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Mizuho decreased their price target on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a research report on Wednesday, October 21st. Finally, KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Company Profile